Chris Womack

1.8k total citations
34 papers, 1.2k citations indexed

About

Chris Womack is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chris Womack has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Chris Womack's work include HER2/EGFR in Cancer Research (4 papers), Cancer Genomics and Diagnostics (4 papers) and PARP inhibition in cancer therapy (4 papers). Chris Womack is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Cancer Genomics and Diagnostics (4 papers) and PARP inhibition in cancer therapy (4 papers). Chris Womack collaborates with scholars based in United Kingdom, United States and Brazil. Chris Womack's co-authors include Neil Gray, Dawn Baker, Neil R. Smith, Ruth Swann, Martin Jenkins, Dugal Heath, Shethah Morgan, Anderson J. Ryan, Kirsty Ratcliffe and Susan Ashton and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Gut.

In The Last Decade

Chris Womack

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Womack United Kingdom	16	595	594	282	205	132	34	1.2k
Alexander C. Klimowicz Canada	23	821 1.4×	653 1.1×	188 0.7×	280 1.4×	182 1.4×	56	1.5k
Clare Orange United Kingdom	19	618 1.0×	428 0.7×	209 0.7×	321 1.6×	122 0.9×	44	1.2k
Maja J.A. de Jonge Netherlands	19	865 1.5×	848 1.4×	420 1.5×	259 1.3×	125 0.9×	40	1.6k
Reena Philip United States	16	402 0.7×	583 1.0×	302 1.1×	293 1.4×	80 0.6×	23	1.1k
Marion T. Weigel Germany	16	481 0.8×	338 0.6×	119 0.4×	275 1.3×	118 0.9×	27	1.1k
Sujatha Jagadeeswaran United States	12	465 0.8×	360 0.6×	169 0.6×	197 1.0×	74 0.6×	16	973
Véronique Ouellet Canada	22	770 1.3×	493 0.8×	205 0.7×	314 1.5×	63 0.5×	47	1.4k
Irina Linkov United States	15	531 0.9×	598 1.0×	351 1.2×	275 1.3×	284 2.2×	27	1.5k
Tomoko Freshwater United States	13	783 1.3×	1.0k 1.7×	213 0.8×	152 0.7×	61 0.5×	27	1.5k
Lin Guo China	21	731 1.2×	332 0.6×	180 0.6×	440 2.1×	96 0.7×	71	1.3k

Countries citing papers authored by Chris Womack

Since Specialization

Citations

This map shows the geographic impact of Chris Womack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Womack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Womack more than expected).

Fields of papers citing papers by Chris Womack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Womack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Womack. The network helps show where Chris Womack may publish in the future.

Co-authorship network of co-authors of Chris Womack

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Womack. A scholar is included among the top collaborators of Chris Womack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Womack. Chris Womack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hodgson, Darren, Brian Dougherty, Zhongwu Lai, et al.. (2018). Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. British Journal of Cancer. 119(11). 1401–1409. 167 indexed citations

Nomura, Hiroyuki, Fumio Kataoka, Daisuke Aoki, et al.. (2016). Expression of potential biomarkers associated with homologous recombination repair in patients with ovarian or triple-negative breast cancer. Cancer Biomarkers. 16(1). 145–152. 9 indexed citations

Howat, William, Arthur Lewis, Caroline Kampf, et al.. (2014). Antibody validation of immunohistochemistry for biomarker discovery: Recommendations of a consortium of academic and pharmaceutical based histopathology researchers. Methods. 70(1). 34–38. 68 indexed citations

Mu, Zhaomei, Teresa Klinowska, Emily Foster, et al.. (2014). AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models. Journal of Experimental & Clinical Cancer Research. 33(1). 47–47. 21 indexed citations

Zhan, Ping, Paul R. Gavine, Shethah Morgan, et al.. (2014). FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study. British Journal of Cancer. 110(4). 967–975. 148 indexed citations

Wilky, Breelyn A., Michelle A. Rudek, Dan Laheru, et al.. (2014). A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours. British Journal of Cancer. 112(1). 24–31. 35 indexed citations

Cumberbatch, Marie, Ximing Tang, Garry Beran, et al.. (2013). Identification of a Subset of Human Non–Small Cell Lung Cancer Patients with High PI3Kβ and Low PTEN Expression, More Prevalent in Squamous Cell Carcinoma. Clinical Cancer Research. 20(3). 595–603. 22 indexed citations

Smith, Neil R., Dawn Baker, Matthew R. Farren, et al.. (2013). Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy. Clinical Cancer Research. 19(24). 6943–6956. 111 indexed citations

Dearden, Simon, Chris Harbron, Darren Hodgson, et al.. (2013). Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 462(3). 269–279. 20 indexed citations

10.

Chenna, Ahmed, Weidong Huang, Gayle Marshall, et al.. (2013). Abstract 3029: Profiling HER3/ErbB3 activation in formalin-fixed, paraffin-embedded (FFPE) breast tumor samples that express high and low HER2/ErbB2 levels using proximity-based immunoassays.. Cancer Research. 73(8_Supplement). 3029–3029. 3 indexed citations

11.

Haslam, Iain S., et al.. (2011). Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue. Biopharmaceutics & Drug Disposition. 32(4). 210–221. 48 indexed citations

12.

Chadwick, Amy L., Chris Womack, Becky M. Bola, et al.. (2011). Abstract 4123: Monocarboxylate transporter 4 expression is a prognostic factor for radiotherapy outcome in squamous cell carcinoma of the head and neck. Cancer Research. 71(8_Supplement). 4123–4123. 1 indexed citations

13.

Senra, Joana M., Emma Donald, Victoria Williams, et al.. (2011). Abstract 5088: Exploring ATM deficiency as a potential therapeutic target for the PARP inhibitor olaparib in head and neck squamous cell carcinoma. Cancer Research. 71(8_Supplement). 5088–5088. 1 indexed citations

14.

Smith, Neil R., Dawn Baker, Neil H. James, et al.. (2010). Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers. Clinical Cancer Research. 16(14). 3548–3561. 197 indexed citations

15.

Bailey, Neil A., Manoj Nanji, Richard Gillies, et al.. (2010). Cytoplasmic β‐catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas. Histopathology. 57(1). 101–111. 14 indexed citations

16.

Rajeshkumar, N.V., Aik Choon Tan, Elizabeth De Oliveira, et al.. (2009). Antitumor Effects and Biomarkers of Activity of AZD0530, a Src Inhibitor, in Pancreatic Cancer. Clinical Cancer Research. 15(12). 4138–4146. 75 indexed citations

17.

Womack, Chris & Neil Gray. (2008). Banking human tissue for research: vision to reality. Cell and Tissue Banking. 10(3). 267–270. 11 indexed citations

18.

Orr, Samantha, Neil Gray, Rivka Ravid, et al.. (2005). Fourth meeting of the European Network of Research Tissue Banks – Future strategy to increase collaborations in the supply of human tissue for biomedical research. Cell and Tissue Banking. 6(2). 131–138. 6 indexed citations

19.

Womack, Chris & Neil Gray. (2000). Human research tissue banks in the UK National Health Service: laws, ethics, controls and constraints.. PubMed. 57(3). 250–3. 15 indexed citations

20.

Harrison, J. Michael, et al.. (1987). Electrohydraulic lithotripsy of gall stones--in vitro and animal studies.. Gut. 28(3). 267–271. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact